1. Home
  2. GROW vs FEMY Comparison

GROW vs FEMY Comparison

Compare GROW & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

N/A

Current Price

$3.31

Market Cap

31.3M

Sector

Finance

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$0.52

Market Cap

37.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GROW
FEMY
Founded
1968
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
37.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
GROW
FEMY
Price
$3.31
$0.52
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
25.3K
381.1K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
2.74%
N/A
EPS Growth
N/A
8.60
EPS
0.05
N/A
Revenue
$23,850,609.00
$1,629,108.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
$66.00
N/A
Revenue Growth
N/A
51.97
52 Week Low
$2.05
$0.31
52 Week High
$3.65
$1.76

Technical Indicators

Market Signals
Indicator
GROW
FEMY
Relative Strength Index (RSI) 60.51 42.05
Support Level $2.33 $0.47
Resistance Level $3.43 $0.58
Average True Range (ATR) 0.11 0.04
MACD -0.02 0.00
Stochastic Oscillator 65.71 30.35

Price Performance

Historical Comparison
GROW
FEMY

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: